Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study

MLA

Tansei Sanjo, et al. “Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-Positive Upper Tract Urothelial Carcinoma? Results of a Multi-Center Cohort Study.” Urologic Oncology: Seminars and Original Investigations, vol. 40, Mar. 2022, p. 105.e19-105.e26. EBSCOhost, https://doi.org/10.1016/j.urolonc.2021.07.029.

APA

Tansei Sanjo, Yuki Arita, Eiji Kikuchi, Yuto Baba, Tetsushi Murakami, Nobuyuki Tanaka, Mototsugu Oya, Kazunori Shojo, Hirotaka Akita, Keisuke Shigeta, Takeo Kosaka, Toshikazu Takeda, Ryuichi Mizuno, Kota Umeda, Kazuhiro Matsumoto, Masahiro Jinzaki, Shinya Morita, Koichiro Ogihara, Mizuki Izawa, & Tadatsugu Anno. (2022). Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study. Urologic Oncology: Seminars and Original Investigations, 40, 105.e19-105.e26. https://doi.org/10.1016/j.urolonc.2021.07.029

Chicago

Tansei Sanjo, Yuki Arita, Eiji Kikuchi, Yuto Baba, Tetsushi Murakami, Nobuyuki Tanaka, Mototsugu Oya, et al. 2022. “Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-Positive Upper Tract Urothelial Carcinoma? Results of a Multi-Center Cohort Study.” Urologic Oncology: Seminars and Original Investigations 40 (March): 105.e19-105.e26. doi:10.1016/j.urolonc.2021.07.029.